A description is not currently available for this report.
Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Increasing prevalence of cancer 3.2.1.2 Growing adoption of chemotherapy 3.2.1.3 Technological advancements in treatment options 3.2.1.4 Rising government initiatives and funding 3.2.2 Industry pitfalls & challenges 3.2.2.1 High cost of treatment 3.2.2.2 Adverse effects of treatment 3.3 Growth potential analysis 3.4 Regulatory landscape 3.5 Pipeline analysis 3.6 Porter's analysis 3.7 PESTEL analysis 3.8 Future market trends Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company matrix analysis 4.3 Competitive analysis of major market players 4.4 Competitive positioning matrix 4.5 Strategy dashboard Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Granulocyte colony-stimulating factor therapy 5.3 Antibiotics 5.4 Granulocyte transfusion 5.5 Antifungals 5.6 Other treatment types Chapter 6 Market Estimates and Forecast, By Drug Type, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Branded 6.3 Biosimilars Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Parenteral 7.3 Oral Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 Hospital pharmacies 8.3 Retail pharmacies 8.4 Online pharmacies Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 9.1 Key trends 9.2 North America 9.2.1 U.S. 9.2.2 Canada 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 France 9.3.4 Spain 9.3.5 Italy 9.3.6 Netherlands 9.3.7 Rest of Europe 9.4 Asia Pacific 9.4.1 China 9.4.2 Japan 9.4.3 India 9.4.4 Australia 9.4.5 South Korea 9.4.6 Rest of Asia Pacific 9.5 Latin America 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Argentina 9.5.4 Rest of Latin America 9.6 Middle East and Africa 9.6.1 South Africa 9.6.2 Saudi Arabia 9.6.3 UAE 9.6.4 Rest of Middle East and Africa Chapter 10 Company Profiles 10.1 Amgen Inc. 10.2 BeyondSpring Inc. 10.3 Biocon Biologics Inc. 10.4 Cellerant Therapeutics 10.5 Coherus BioSciences, Inc. 10.6 Evive Biotech 10.7 Kyowa Kirin Co., Ltd. 10.8 Novartis AG 10.9 Pfizer Inc. 10.10 Sanofi 10.11 Spectrum Pharmaceuticals 10.12 Teva Pharmaceutical Industries Ltd.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook